In this direction, it was shown recently that autocrine production of NTN1 in aggressive neuroblastomas conveys selective advantage for tumor growth and dissemination [8], as it blocks the pro-apoptotic activity of the NTN1 receptors, UNC5H, leading to resistance to apoptosis that is a prerequisite for neuroblastoma progression. This evidence concerns the gene NTN1 and neoplasm.